Investigators explore the effectiveness of new combination therapies to address the multifactorial pathophysiology of acne vulgaris.
Nicholas Brownstone, MD
Advertisement
Articles by Nicholas Brownstone, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease
2
FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy
3
New sunscreen ingredient clears FDA for the first time since the 1990s
4
FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis
5